Download PDF
Semin intervent Radiol 2005; 22(4): 309-315
DOI: 10.1055/s-2005-925557
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Transjugular Intrahepatic Portosystemic Shunts in Patients with Hepatic Malignancy

Michael J. Wallace1 , David C. Madoff1
  • 1Department of Diagnostic Radiology, Section of Interventional Radiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Further Information

Publication History

Publication Date:
03 January 2006 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Since its first clinical application in 1988, the transjugular intrahepatic portosystemic shunt (TIPS) has emerged as a safe and effective means of managing patients with morbid portal hypertension. Despite the considerable body of literature on TIPS, portal decompression in patients with malignancy has not been sufficiently examined. These patients typically experience sequelae of portal hypertension that requires palliation. The purpose of this article is to review the reported experience with TIPS in patients with malignancy.

KEYWORDS

Hepatic neoplasm - interventional procedure - portosystemic shunt - portal hypertension

REFERENCES

  • 1 Cello J P, Ring E J, Olcott E W et al.. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: a randomized, controlled trial.  Ann Intern Med. 1997;  126 858-865
    PubMedGoogle Scholar
  • 2 Rossle M, Deibert P, Haag K et al.. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.  Lancet. 1997;  349 1043-1049
    CrossrefPubMedGoogle Scholar
  • 3 Pomier-Layrargues G, Villeneuve J P, Deschenes M et al.. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.  Gut. 2001;  48 390-396
    CrossrefPubMedGoogle Scholar
  • 4 Rossle M, Ochs A, Gulberg V et al.. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.  N Engl J Med. 2000;  342 1701-1707
    CrossrefPubMedGoogle Scholar
  • 5 Gordon F D, Anastopoulos H T, Crenshaw W et al.. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.  Hepatology. 1997;  25 1366-1369
    CrossrefPubMedGoogle Scholar
  • 6 Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum H E, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients.  Eur J Gastroenterol Hepatol. 2001;  13 529-534
    CrossrefPubMedGoogle Scholar
  • 7 Perello A, Garcia-Pagan J C, Gilabert R et al.. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.  Hepatology. 2002;  35 132-139
    CrossrefPubMedGoogle Scholar
  • 8 Blum U, Rossle M, Haag K et al.. Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt.  Radiology. 1995;  197 805-811
    PubMedGoogle Scholar
  • 9 Haskal Z J, Martin L, Cardella J F et al.. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. SCVIR Standards of Practice Committee.  J Vasc Interv Radiol. 2001;  12 131-136
    PubMedGoogle Scholar
  • 10 Nakamura K, Hamuro M, Nishida N, Kaminou T, Satoh K, Matsuoka T. Hepatocellular Carcinoma and Portal Hypertension: Indication for Transjugular Intrahepatic Portosystemic Shunt. Chicago, IL; Radiological Society of North America 2002
    Google Scholar
  • 11 Sakaguchi H, Uchida H, Maeda M et al.. Combined transjugular intrahepatic portosystemic shunt and segmental Lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report.  Cardiovasc Intervent Radiol. 1995;  18 9-15
    PubMedGoogle Scholar
  • 12 Wallace M J, Madoff D C, Ahrar K, Warneke C L. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting.  Cancer. 2004;  101 337-345
    CrossrefPubMedGoogle Scholar
  • 13 Azoulay D, Buabse F, Damiano I et al.. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension.  J Am Coll Surg. 2001;  193 46-51
    CrossrefPubMedGoogle Scholar
  • 14 Zuckerman D A, Darcy M D, Bocchini T P, Hildebolt C F. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors.  AJR Am J Roentgenol. 1997;  169 1727-1731
    PubMedGoogle Scholar
  • 15 LaBerge J M, Ring E J, Gordon R L et al.. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients.  Radiology. 1993;  187 413-420
    CrossrefPubMedGoogle Scholar
  • 16 Hidajat N, Vogl T, Stobbe H et al.. Transjugular intrahepatic portosystemic shunt: experiences at a liver transplantation center.  Acta Radiol. 2000;  41 474-478
    CrossrefPubMedGoogle Scholar
  • 17 Malinchoc M, Kamath P S, Gordon F D, Peine C J, Rank J, ter Borg P C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.  Hepatology. 2000;  31 864-871
    CrossrefPubMedGoogle Scholar
  • 18 Barton R E, Rosch J, Saxon R R, Lakin P C, Petersen B D, Keller F S. TIPS-short and long-term results: a survey of 1750 patients.  Semin Intervent Radiol. 1995;  12 364-367
    PubMedGoogle Scholar
  • 19 Jiang Z B, Shan H, Shen X Y et al.. Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis.  World J Gastroenterol. 2004;  10 1881-1884
    PubMedGoogle Scholar
  • 20 Otal P, Smayra T, Bureau C et al.. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures.  AJR Am J Roentgenol. 2002;  178 141-147
    CrossrefPubMedGoogle Scholar
  • 21 Hur J, Lee K H, Lee J H, Yu J S, Won J Y, Lee D Y. Stent-graft for TIPS in a hepatocellular carcinoma patient with main portal vein invasion.  AJR Am J Roentgenol. 2004;  182 1301-1304
    PubMedGoogle Scholar
  • 22 Petersen B. Intravascular ultrasound-guided direct intrahepatic portacaval shunt: description of technique and technical refinements.  J Vasc Interv Radiol. 2003;  14 21-32
    PubMedGoogle Scholar
  • 23 Soares G M, Murphy T P. Transcaval TIPS: indications and anatomic considerations.  J Vasc Interv Radiol. 1999;  10 1233-1238
    PubMedGoogle Scholar
  • 24 Walser E M, NcNees S W, DeLa Pena O et al.. Portal venous thrombosis: percutaneous therapy and outcome.  J Vasc Interv Radiol. 1998;  9 119-127
    CrossrefPubMedGoogle Scholar
  • 25 Radosevich P M, Ring E J, LaBerge J M et al.. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion.  Radiology. 1993;  186 523-527
    PubMedGoogle Scholar
  • 26 Matsui O, Yoshikawa J, Kadoya M et al.. Transjugular intrahepatic portosystemic shunt after previous recanalization of a chronically thrombosed portal vein via a transmesenteric approach.  Cardiovasc Intervent Radiol. 1996;  19 352-355
    CrossrefPubMedGoogle Scholar
  • 27 Yamagami T, Nakamura T, Tanaka O, Akada W, Takayama T, Maeda T. Transjugular intrahepatic portosystemic shunt after complete obstruction of portal vein.  J Vasc Interv Radiol. 1999;  10 575-578
    PubMedGoogle Scholar
  • 28 Jalan R, Lui H F, Redhead D N, Hayes P C. TIPSS 10 years on.  Gut. 2000;  46 578-581
    CrossrefPubMedGoogle Scholar
  • 29 Saxon R S, Ross P L, Mendel-Hartvig J et al.. Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms.  Radiology. 1998;  207 683-693
    CrossrefPubMedGoogle Scholar
  • 30 Wallace M, Swaim M. Transjugular intrahepatic portosystemic shunts through hepatic neoplasms.  J Vasc Interv Radiol. 2003;  14 501-507
    CrossrefPubMedGoogle Scholar
  • 31 Saxon R R, Mendel-Hartvig J, Corless C L et al.. Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine.  J Vasc Interv Radiol. 1996;  7 487-497
    CrossrefPubMedGoogle Scholar
  • 32 Hausegger K A, Karnel F, Georgieva B et al.. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.  J Vasc Interv Radiol. 2004;  15 239-248
    CrossrefPubMedGoogle Scholar
  • 33 Encarnacion C E, Palmaz J C, Rivera F J et al.. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality.  J Vasc Interv Radiol. 1995;  6 687-694
    PubMedGoogle Scholar
  • 34 Coldwell D M, Ring E J, Rees C R et al.. Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension.  Radiology. 1995;  196 335-340
    CrossrefPubMedGoogle Scholar
  • 35 Gines P, Uriz J, Calahorra B et al.. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.  Gastroenterology. 2002;  123 1839-1847
    CrossrefPubMedGoogle Scholar
  • 36 Ferral H, Vasan R, Speeg K V et al.. Evaluation of a model to predict poor survival in patients undergoing elective TIPS procedures.  J Vasc Interv Radiol. 2002;  13 1103-1108
    CrossrefPubMedGoogle Scholar
  • 37 Angermayr B, Cejna M, Karnel F et al.. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.  Gut. 2003;  52 879-885
    CrossrefPubMedGoogle Scholar

Michael J WallaceM.D. 

Department of Diagnostic Radiology, Section of Interventional Radiology, Unit 325

The University of Texas M.D. Anderson Cancer Center

1515 Holcombe Boulevard, Houston, TX 77030-4009

      >